• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2022 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Clinical Trials
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • Points of Discussion Podcast
        • Mentorship Program
        • Education Archive
        • 2022 PeDRA Annual Conference
        • Early Investigator Support
        • Dash for Discovery Fun Run/Walk
        • Events Calendar
        • Join PeDRA Friday, May 20th in Portland, OR for our session, Pediatric Dermatology at the 2022 SID Annual Meeting! #PeDRAatSID2022

  • Research
        • Grants & Awards
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Clinical Trials
        • 2022 Childhood Eczema Challenge Grant applications are now being accepted with a June 1st deadline.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • NOW HIRING! Explore current opportunities at PeDRA.

  • Member Login

What does a pediatric BAP1 inactivated melanocytic tumor (BIMT) look like?

April 9, 2020 By Katherine Devenport

Principal Investigator:

Elena Hawryluk, MD, PhD
Massachusetts General Hospital

Overview:

Spitz nevi are a type of skin growth that occur most commonly in children. This study seeks to better understand Spitz nevi in children by determining possible overlap with a different entity known as BAP1 inactivated melanocytic tumors (BIMTs). BIMTs have many microscopic features that overlap with Spitz nevi, but are not well studied in children. Providers encountering BIMTs in children are not in agreement for the most appropriate management for these patients given the lack of data on these tumors.
We propose to study these tumors by performing special stains (BAP1, BRAF) on previously collected tissue for 30 identified cases of combined Spitz and dermal nevi. By better understanding these skin growths, we will be able to better assess if this subset of Spitz nevi should be re-characterized as BIMTs, and help shed light on the understanding and management of these poorlycharacterized skin growths in the pediatric population.

Status:

This project was funded by a 2019 PeDRA Research Grant.

Filed Under: Skin Tumors and Reactions to Cancer Therapies

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2022 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy